{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:08:06Z","timestamp":1790197686707,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.seizure.2022.01.019","type":"journal-article","created":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T10:33:40Z","timestamp":1644057220000},"page":"79-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Outcomes of parenteral vs enteral ketogenic diet in pediatric super-refractory status epilepticus"],"prefix":"10.1016","volume":"96","author":[{"given":"Sirinuch","family":"Chomtho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaraspong","family":"Uaariyapanichkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisnachai","family":"Chomtho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 8","key":"10.1016\/j.seizure.2022.01.019_bib0001","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1528-1167.2011.03238.x","article-title":"Super-refractory status epilepticus: an approach to therapy in this difficult clinical situation","volume":"52","author":"Shorvon","year":"2011","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.seizure.2022.01.019_bib0002","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jamaneurol.2013.578","article-title":"Predictors of outcome in refractory status epilepticus","volume":"70","author":"Hocker","year":"2013","journal-title":"JAMA Neurol"},{"issue":"Pt 8","key":"10.1016\/j.seizure.2022.01.019_bib0003","first-page":"2314","article-title":"The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy","volume":"135","author":"Ferlisi","year":"2012","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.seizure.2022.01.019_bib0004","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ejpn.2015.05.007","article-title":"Etiology, clinical course and response to the treatment of status epilepticus in children: a 16-year single-center experience based on 602 episodes of status epilepticus","volume":"19","author":"Kravljanac","year":"2015","journal-title":"Eur J Paediatr Neurol"},{"issue":"11","key":"10.1016\/j.seizure.2022.01.019_bib0005","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1046\/j.1528-1157.2001.21301.x","article-title":"Outcome of severe refractory status epilepticus in children","volume":"42","author":"Sahin","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2022.01.019_bib0006","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.seizure.2018.05.012","article-title":"Pediatric refractory and super-refractory status epilepticus","volume":"68","author":"Vasquez","year":"2019","journal-title":"Seizure"},{"issue":"5","key":"10.1016\/j.seizure.2022.01.019_bib0007","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/1535759720928269","article-title":"Treatment of refractory convulsive status epilepticus: a comprehensive review by the American Epilepsy Society Treatments Committee","volume":"20","author":"Vossler","year":"2020","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.seizure.2022.01.019_bib0008","doi-asserted-by":"crossref","DOI":"10.1177\/1535759721999670","article-title":"Treatment of super-refractory status epilepticus: a review","author":"Ochoa","year":"2021","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.seizure.2022.01.019_bib0009","article-title":"Ketogenic diets for drug-resistant epilepsy","volume":"6","author":"Martin-McGill","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.seizure.2022.01.019_bib0010","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1528-1157.2002.47901.x","article-title":"Acetoacetate, acetone, and dibenzylamine (a contaminant in l-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo","volume":"43","author":"Rho","year":"2002","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.seizure.2022.01.019_bib0011","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ana.10634","article-title":"Anticonvulsant properties of acetone, a brain ketone elevated by the ketogenic diet","volume":"54","author":"Likhodii","year":"2003","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.seizure.2022.01.019_bib0012","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neuron.2010.09.002","article-title":"Metabolic control of vesicular glutamate transport and release","volume":"68","author":"Juge","year":"2010","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.seizure.2022.01.019_bib0013","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuroscience.2006.11.065","article-title":"Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation","volume":"145","author":"Maalouf","year":"2007","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.seizure.2022.01.019_bib0014","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1111\/epi.13038","article-title":"Ketogenic diet exhibits anti-inflammatory properties","volume":"56","author":"Dupuis","year":"2015","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.seizure.2022.01.019_bib0015","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.seizure.2022.01.019_bib0016","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.pediatrneurol.2014.12.008","article-title":"Group CS. Intravenous ketogenic diet therapy for treatment of the acute stage of super-refractory status epilepticus in a pediatric patient","volume":"52","author":"Lin","year":"2015","journal-title":"Pediatr Neurol"},{"issue":"6","key":"10.1016\/j.seizure.2022.01.019_bib0017","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.ejpn.2016.08.004","article-title":"From intravenous to enteral ketogenic diet in PICU: a potential treatment strategy for refractory status epilepticus","volume":"20","author":"Chiusolo","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"issue":"5","key":"10.1016\/j.seizure.2022.01.019_bib0018","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1684\/epd.2019.1095","article-title":"Ketogenic parenteral nutrition in three paediatric patients with epilepsy with migrating focal seizures","volume":"21","author":"Armeno","year":"2019","journal-title":"Epileptic Disord"},{"issue":"6 Pt B","key":"10.1016\/j.seizure.2022.01.019_bib0019","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.clnu.2018.06.946","article-title":"ESPGHAN\/ESPEN\/ESPR\/CSPEN guidelines on pediatric parenteral nutrition: lipids","volume":"37","author":"Lapillonne","year":"2018","journal-title":"Clin Nutr"},{"issue":"4","key":"10.1016\/j.seizure.2022.01.019_bib0020","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.braindev.2018.11.011","article-title":"Treatment options in pediatric super-refractory status epilepticus","volume":"41","author":"Arayakarnkul","year":"2019","journal-title":"Brain Dev"},{"issue":"2","key":"10.1016\/j.seizure.2022.01.019_bib0021","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12028-016-0312-4","article-title":"A practical approach to ketogenic diet in the pediatric intensive care unit for super-refractory status epilepticus","volume":"26","author":"Farias-Moeller","year":"2017","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.seizure.2022.01.019_bib0022","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.seizure.2016.07.006","article-title":"Ketogenic diet treatment for pediatric super-refractory status epilepticus","volume":"41","author":"Appavu","year":"2016","journal-title":"Seizure"},{"issue":"8","key":"10.1016\/j.seizure.2022.01.019_bib0023","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.0000000000000151","article-title":"Ketogenic diet for adults in super-refractory status epilepticus","volume":"82","author":"Thakur","year":"2014","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.seizure.2022.01.019_bib0024","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/0883073813516192","article-title":"The ketogenic diet as broad-spectrum treatment for super-refractory pediatric status epilepticus: challenges in implementation in the pediatric and neonatal intensive care units","volume":"30","author":"Cobo","year":"2015","journal-title":"J Child Neurol"},{"key":"10.1016\/j.seizure.2022.01.019_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.669296","article-title":"Ketogenic diet in the treatment of super-refractory status epilepticus at a pediatric intensive care unit: a single-center experience","volume":"12","author":"Breu","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.seizure.2022.01.019_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.643105","article-title":"Dietary management of children with super-refractory status epilepticus: a systematic review and experience in a single UK Tertiary Centre","volume":"12","author":"Schoeler","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.seizure.2022.01.019_bib0027","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4103\/ijpvm.IJPVM_281_16","article-title":"Association of omega-3 fatty acid and epileptic seizure in epileptic patients: a systematic review","volume":"9","author":"Pourmasoumi","year":"2018","journal-title":"Int J Prev Med"},{"issue":"10","key":"10.1016\/j.seizure.2022.01.019_bib0028","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1111\/j.1528-1167.2010.02703.x","article-title":"Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES)","volume":"51","author":"Nabbout","year":"2010","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.seizure.2022.01.019_bib0029","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.braindev.2018.12.007","article-title":"The ketogenic diet for super-refractory status epilepticus patients in intensive care units","volume":"41","author":"Park","year":"2019","journal-title":"Brain Dev"},{"issue":"1","key":"10.1016\/j.seizure.2022.01.019_bib0030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/epi4.12084","article-title":"Ketogenic parenteral nutrition in 17 pediatric patients with epilepsy","volume":"3","author":"Dressler","year":"2018","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.seizure.2022.01.019_bib0031","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3389\/fneur.2019.00423","article-title":"Ketogenic diet as a treatment for super-refractory status epilepticus in febrile infection-related epilepsy syndrome","volume":"10","author":"Peng","year":"2019","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.seizure.2022.01.019_bib0032","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/dmcn.14306","article-title":"Optimal clinical management of children receiving ketogenic parenteral nutrition: a clinical practice guide","volume":"62","author":"van der Louw","year":"2020","journal-title":"Dev Med Child Neurol"},{"issue":"8","key":"10.1016\/j.seizure.2022.01.019_bib0033","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.braindev.2011.11.008","article-title":"Safety and role of ketogenic parenteral nutrition for intractable childhood epilepsy","volume":"34","author":"Jung","year":"2012","journal-title":"Brain Dev"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131122000279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131122000279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T02:00:22Z","timestamp":1761012022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131122000279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":33,"alternative-id":["S1059131122000279"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2022.01.019","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of parenteral vs enteral ketogenic diet in pediatric super-refractory status epilepticus","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2022.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}